Building Stronger Quality Systems for Sustainable Compliance
GH Strategies partners with pharmaceutical, medical device, and biotechnology companies to design, implement, and refine Quality Management Systems that withstand the full rigor of regulatory, certification, and global partner oversight.
What We Offer
Gap Assessments and Readiness Reports
Independent evaluations that identify compliance gaps and deliver actionable improvement roadmaps.
Quality Management System Design and Documentation
Development of SOPs, quality manuals, and controlled records tailored to ISO 9001 and GMP standards.
Mock Certification and Inspection Audits
Simulated audits that prepare your business for real regulatory and certification reviews.
Internal Auditor Training and Capacity Building
Practical training for your team to conduct effective internal audits, delivered on-site or virtually.
Support in Selecting Accredited Certification Bodies
Guidance on identifying and engaging the right certification partner for your business needs.
Ongoing QMS Maintenance and Continuous Improvement
Lifecycle support to keep your systems aligned with evolving standards and best practices.
Is Your Quality System Audit-Ready?
Speak to an Expert.
Benefits of Choosing GH Strategies
Confidence in Every Audit
Customised Systems
Sustainable Compliance
Quality Systems Designed for Consistent Performance
Practical quality approaches that strengthen everyday operations, improve compliance confidence, and align your business with ISO and global expectations.
Frequently Asked Questions (FAQs)
A Quality Management System is the structured set of policies, procedures, records, and controls that ensure products are consistently manufactured, stored, and distributed in line with regulatory and safety requirements. In pharma and MedTech, a QMS typically aligns with standards such as ISO 13485 and GMP, covering document control, risk management, training, CAPA, audits, and continual improvement.
For medical devices and IVDs, ISO 13485 is increasingly treated as the baseline quality standard. SAHPRA has issued guidance indicating that ISO 13485 certification is a prerequisite for certain medical device establishment licences, and many regulators and customers expect it for market access. GH Strategies helps organisations design, implement, and maintain ISO 13485-aligned QMSs that support both SAHPRA licensing and broader global market entry.
Timelines depend on company size, existing systems, and product complexity. Many organisations require several months to move from gap assessment to a functioning ISO 13485 or GMP-compliant QMS, with typical implementation cycles often ranging from three to six months when the project is properly resourced. GH Strategies uses structured gap assessments, prioritised action plans, and staged implementation to shorten timelines and reduce rework.
A specialist quality and compliance consultant provides an independent view of your systems, identifies gaps, and helps you correct them before authorities or certification bodies arrive on site. This support usually includes mock audits, documentation reviews, staff training, CAPA planning, and readiness reports that mirror real inspection criteria, which significantly improves audit outcomes and reduces the risk of critical or major findings.
ISO 13485 is an international QMS standard specific to medical devices and IVDs, while Good Manufacturing Practice focuses on how medicines and certain health products are manufactured, and Good Distribution Practice governs storage, handling, and distribution activities. Together, these frameworks ensure that products are designed, produced, stored, and delivered in a way that protects patient safety and meets regulatory expectations. GH Strategies designs integrated systems that align with all three where required, rather than treating them as separate, conflicting requirements.
Typical preparation steps include a structured gap assessment against the relevant standard or guideline, remediation of identified gaps, validation or qualification of critical processes, internal audits, and targeted training for staff who will interact with inspectors. GH Strategies supports clients through each of these steps, including mock inspections and evidence preparation, so that quality and compliance can be demonstrated clearly and confidently during ISO, GMP, GDP, or regulatory audits.
From the Newsroom
Launching the GH Strategies Institute: Empowering Pharma and MedTech Professionals Through e-Learning
There are moments in every industry when progress demands a new way of thinking. For…
Strengthening Pharmacovigilance Systems: GH Strategies’ Vision for Safer Healthcare
Every medicine, vaccine, and medical device carries the promise of better health, but also the…
SAHPRA Requires ISO 13485 Certification for Medical Device Establishment Licences in South Africa
In April 2025, the South African Health Products Regulatory Authority (SAHPRA) formally announced that medical…
Optimising the Clinical Supply Chain: GH Strategies’ Role in Global Trial Readiness from South Africa
Clinical trials depend on precision – not only in research design but also in how…